-
Signature
-
/s/ Robin Schulman
-
Issuer symbol
-
GTLB
-
Transactions as of
-
02 Jan 2025
-
Net transactions value
-
-$972,723
-
Form type
-
4
-
Filing time
-
03 Jan 2025, 17:56:44 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
GTLB |
Class A Common Stock |
Sale |
$417,663 |
-7,330 |
-5.7% |
$56.98 |
121,893 |
02 Jan 2025 |
Direct |
F1 |
| transaction |
GTLB |
Class A Common Stock |
Conversion of derivative security |
$0 |
+9,251 |
+7.6% |
$0.000000 |
131,144 |
03 Jan 2025 |
Direct |
F2 |
| transaction |
GTLB |
Class A Common Stock |
Sale |
$555,060 |
-9,251 |
-7.1% |
$60.00 |
121,893 |
03 Jan 2025 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
GTLB |
Stock Option (Right to buy Class B Common Stock) |
Options Exercise |
$0 |
-9,251 |
-20% |
$0.000000 |
37,004 |
03 Jan 2025 |
Class B Common Stock |
9,251 |
$8.90 |
Direct |
F1, F4 |
| transaction |
GTLB |
Class B Common Stock |
Options Exercise |
|
+9,251 |
|
|
9,251 |
03 Jan 2025 |
Class A Common Stock |
9,251 |
$8.90 |
Direct |
F1, F2 |
| transaction |
GTLB |
Class B Common Stock |
Conversion of derivative security |
|
-9,251 |
-100% |
|
0 |
03 Jan 2025 |
Class A Common Stock |
9,251 |
|
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: